Showing results (811-820 of 1,120) with videos related to

Sort By:
Pageof 112
The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Not Undergoing DialysisAjay K Singh, Kevin Carroll, John J V McMurray, et al.
Journal of the American College of Cardiology|August 27, 2025
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM TrialMilind Y Desai, Iacopo Olivotto, Theodore Abraham, et al.
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
American Heart Journal|May 17, 2026
Cardiovascular Regulatory Science: Accelerating the Path from Bench to BedsideSerge Korjian, C Michael Gibson, Jonathan Seltzer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
Journal of Thrombosis and Thrombolysis|March 27, 2009
Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, BrazilRenato D Lopes, Richard C Becker, David Garcia, et al.
The New England Journal of Medicine|November 17, 2020
Sotagliflozin in Patients with Diabetes and Chronic Kidney DiseaseDeepak L Bhatt, Michael Szarek, Bertram Pitt, et al.
Circulation|November 6, 2022
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled TrialSean D Pokorney, Glenn M Chertow, Hussein R Al-Khalidi, et al.
Pageof 112